Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BioTelemetry, Inc.
US-China Decoupling Gets On Biotech's Nerves
The Biden Administration’s latest Executive Order is aimed at shoring up investment in the US and securing supply chains for pharma and biotech products and is already impacting China's CDMO sector, but the long-term impact may be more nuanced, experts predict.
Going Early For Maximum Long Term Value From Medtech Deals
Strategics pursuing high growth M&A plays are often ready to pay a premium price for a target. But with medtech valuations at historic highs, they cannot afford to do that every time. One solution is to take a strategic stake and build early, according to an AdvaMed panel hosted by EY’s John Babitt.
CEO: Triple Headwind Cannot Blow Philips Off Strategic Course
Frans van Houten has promised a summer update on Royal Philips’ medium-term outlook after the company was hit from all sides in late 2021. He expects the resulting headwinds to persist into early 2022.
Minute Insight: Withings Continues Push Into Wearables With Two Acquisitions
The consumer device company recently bought 8Fit, a German fitness app developer, and Impeto Medical, the developer of the Sudoscan technology for detecting and tracking small fiber neuropathy.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Artificial Intelligence
- Other Names / Subsidiaries
- ADEA Medical AB
- BioTel Care
- LifeWatch AG
- Telcare Medical Supply
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.